The Novartis AG (NVS) ROIC is 17.3%, compared to the industry median of (14.6%) and the 5-year historical average of 10.8%.
The Novartis AG (NVS) ROIC minus WACC is 11.0%, compared to the industry median of (9.1%) and the 5-year historical average of 5.7%.
The Novartis AG (NVS) ROE is 27.6%, compared to the industry median of (18.5%) and the 5-year historical average of 20.8%.
The Novartis AG (NVS) ROCE is 17.6%, compared to the industry median of (12.3%) and the 5-year historical average of 10.5%.